Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The cell of origin of ovarian epithelial tumours.

Dubeau L.

Lancet Oncol. 2008 Dec;9(12):1191-7. doi: 10.1016/S1470-2045(08)70308-5. Review.

2.

Coming into focus: the nonovarian origins of ovarian cancer.

Dubeau L, Drapkin R.

Ann Oncol. 2013 Nov;24 Suppl 8:viii28-viii35. doi: 10.1093/annonc/mdt308. Review.

3.
4.

Inhibitory role of prohibitin in human ovarian epithelial cancer.

Jia L, Ren JM, Wang YY, Zheng Y, Zhang H, Zhang Q, Kong BH, Zheng WX.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2247-55. eCollection 2014.

5.

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Vang R, Shih IeM, Kurman RJ.

Histopathology. 2013 Jan;62(1):44-58. doi: 10.1111/his.12046. Review.

PMID:
23240669
6.

Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

Piek JM, Kenemans P, Verheijen RH.

Am J Obstet Gynecol. 2004 Sep;191(3):718-32. Review.

PMID:
15467531
7.

Tubal origin of 'ovarian' low-grade serous carcinoma.

Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B, Zheng W.

Mod Pathol. 2011 Nov;24(11):1488-99. doi: 10.1038/modpathol.2011.106. Epub 2011 Jun 24.

9.

Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.

Wu R, Zhai Y, Kuick R, Karnezis AN, Garcia P, Naseem A, Hu TC, Fearon ER, Cho KR.

J Pathol. 2016 Nov;240(3):341-351. doi: 10.1002/path.4783.

PMID:
27538791
11.

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.

Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1891.

PMID:
20861711
12.

Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol.

Mingels MJ, van Ham MA, de Kievit IM, Snijders MP, van Tilborg AA, Bulten J, Massuger LF.

Mod Pathol. 2014 Jul;27(7):1002-13. doi: 10.1038/modpathol.2013.212. Epub 2013 Dec 6.

13.

Fallopian tube origin of supposed ovarian high-grade serous carcinomas.

Diniz PM, Carvalho JP, Baracat EC, Carvalho FM.

Clinics (Sao Paulo). 2011;66(1):73-6.

14.

Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.

Staff S, Tolonen T, Laasanen SL, Mecklin JP, Isola J, Mäenpää J.

Int J Gynecol Pathol. 2014 May;33(3):309-16. doi: 10.1097/PGP.0b013e31829c673b.

PMID:
24681744
15.

Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Winchester C, Robertson S, MacLeod T, Johnson K, Thomas M.

J Clin Pathol. 2000 Mar;53(3):212-7.

16.

Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.

Fujiwara K, McAlpine JN, Lheureux S, Matsumura N, Oza AM.

Am Soc Clin Oncol Educ Book. 2016;35:e247-57. doi: 10.14694/EDBK_158675. Review.

17.

Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.

Esselen KM, Ng SK, Hua Y, White M, Jimenez CA, Welch WR, Drapkin R, Berkowitz RS, Ng SW.

Gynecol Oncol. 2014 Feb;132(2):316-21. doi: 10.1016/j.ygyno.2013.12.007. Epub 2013 Dec 13.

PMID:
24333360
18.

Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.

Shan W, Mercado-Uribe I, Zhang J, Rosen D, Zhang S, Wei J, Liu J.

Cell Cycle. 2012 Jun 1;11(11):2107-13. doi: 10.4161/cc.20544. Epub 2012 Jun 1.

19.

Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.

Banet N, Kurman RJ.

Int J Gynecol Pathol. 2015 Jan;34(1):3-8. doi: 10.1097/PGP.0000000000000120.

PMID:
25473746
20.

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr, Lu KH.

Clin Cancer Res. 2005 Sep 1;11(17):6116-26.

Supplemental Content

Support Center